Increasing placebo response rates represent a significant barrier to detecting treatment effects in pediatric psychiatry clinical trials. To identify biomarkers for it in adolescents with generalized anxiety disorder prior to their entering a clinical trial, whole brain dynamic and static functional connectivity (FC) were used. Dynamic and static FC between the amygdala, dorsal anterior cingulate cortex, ventrolateral prefrontal cortex and regions that subserve emotion control and inhibition were significantly associated with degree of placebo response and differed between placebo responders and non-responders. These findings may be used to decrease placebo response in clinical trials to more effectively evaluate novel treatments.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords